Comparison of clinical and economic evaluation between selected generic and original febuxostat tablets in Chinese gout patients with hyperuricemia: A real-world multicenter retrospective study

Xia Si,Lin Huang,Qingming Ding,Wei Zhang,Rui Zhao,Chao Ai,Zhuoling An,Gang Liu,Chunyan Zhang,Xue Zhong,Yufei Feng

DOI: https://doi.org/10.1097/md.0000000000037081

IF: 1.6

2024-02-03

Medicine

Abstract:Serum uric acid (SUA) is the final metabolic product of purines in humans. [ 1 ] In Chinese clinical practice and research, hyperuricemia is diagnosed when fasting SUA levels> 420 μmol/L after consumption of a normal purine diet on 2 separate days, regardless of gender. [ 2 , 3 ] Hyperuricemia is a common disorder that affects patients of all ages and genders. [ 4 ] Gout is an inflammatory arthritis caused by the deposition of monosodium urate crystals in the joints and soft tissues, the most important risk factor of which is hyperuricemia. [ 5 ] Recently, a variety of studies have suggested that both gout and hyperuricemia are not only significantly associated with many cardiovascular and metabolic diseases, [ 6 ] but also independent risk factors for premature mortality. [ 7 ] Partly due to the unhealthy lifestyle and the aggravation of population aging, the prevalence and incidence of gout and hyperuricemia has been constantly increasing in China, with the younger generation being affected more. [ 8 , 9 ] According to a recent survey from 31 provinces in mainland China, the weighted prevalence rates of hyperuricemia and gout in Chinese adults were 17.7% and 3.2%, respectively. [ 9 ] The findings suggest hyperuricemia and gout have become major public health concerns in China, and urgent measures are needed to reduce the large burden of these conditions.

medicine, general & internal